Novel Pharmacologic Approaches to Eosinophilic Esophagitis

Puntos clave

• Eosinophilic esophagitis treatment significantly improves inflammation and symptoms.
• Efficacy metrics include reduction of eosinophils by 60% in treated patients.
• Assessment using clinical trials with various biologics and immune modulators has been conducted.
• These novel therapies may enable better management of eosinophilic esophagitis in affected individuals.